Guidance for industry : INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information.
| Other author | Center for Drug Evaluation and Research (U.S.) |
| Format | Electronic |
| Publication Info | [Rockville, MD] : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2003] |
| Description | 1 electronic resource (24 p.) |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS120770 |
| Subjects |
| Portion of title | INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information |
| General note | "CMC." |
| General note | "May 2003." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references (p. 23-24). |
| GPO item number | 0499-T (online) |
| Govt. docs number | HE 20.4702:IN 8/4 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |